glp 1 agonist moa GLP-1 and Anesthesia: Considerations and Cautions for CRNAs Mechanisms of Action and Therapeutic

Laboratory studies have demonstrated that GLP-1 receptor activation can reduce the production of pro-inflammatory cytokines, including tumour necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)

[DOI] [PMC free article] [PubMed] [Google Scholar] 39.Jastreboff A.M., Kaplan L.M., Fras J.P., Wu Q., Du Y., Gurbuz S., Coskun T., Haupt A., Milicevic Z., Hartman M.L

In Australia, PBS status is central

Diabetes Care 45(1):134141 Koekkoek PS, Kappelle LJ, van den Berg E, Rutten GE, Biessels GJ (2015) Cognitive function in patients with diabetes mellitus: guidance for daily care

In the STEP2 research, nearly 1200 obese T2D were given 1 mg, 2.4 mg, or a placebo monthly